MX2015012124A - Composiciones y metodos para dirigir n-acetilglucosamina transferasa o-enlazada y promover la sanacion de heridas. - Google Patents
Composiciones y metodos para dirigir n-acetilglucosamina transferasa o-enlazada y promover la sanacion de heridas.Info
- Publication number
- MX2015012124A MX2015012124A MX2015012124A MX2015012124A MX2015012124A MX 2015012124 A MX2015012124 A MX 2015012124A MX 2015012124 A MX2015012124 A MX 2015012124A MX 2015012124 A MX2015012124 A MX 2015012124A MX 2015012124 A MX2015012124 A MX 2015012124A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- targeting
- wound healing
- linked
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01186—Glycogenin glucosyltransferase (2.4.1.186)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01255—Protein O-GlcNAc transferase (2.4.1.255)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Power Engineering (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361775937P | 2013-03-11 | 2013-03-11 | |
| PCT/US2014/023525 WO2014164805A1 (en) | 2013-03-11 | 2014-03-11 | Compositions and methods for targeting o-linked n-acetylglucosamine transferase and promoting wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015012124A true MX2015012124A (es) | 2016-04-28 |
Family
ID=51658978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012124A MX2015012124A (es) | 2013-03-11 | 2014-03-11 | Composiciones y metodos para dirigir n-acetilglucosamina transferasa o-enlazada y promover la sanacion de heridas. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20170166897A1 (enExample) |
| EP (1) | EP2970978A4 (enExample) |
| JP (1) | JP2016513968A (enExample) |
| KR (1) | KR20150126048A (enExample) |
| CN (1) | CN105408480A (enExample) |
| AU (1) | AU2014248966A1 (enExample) |
| BR (1) | BR112015022701A2 (enExample) |
| CA (1) | CA2905337A1 (enExample) |
| CL (1) | CL2015002599A1 (enExample) |
| MX (1) | MX2015012124A (enExample) |
| RU (1) | RU2015138544A (enExample) |
| SG (1) | SG11201507211YA (enExample) |
| WO (1) | WO2014164805A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12146883B2 (en) * | 2018-12-06 | 2024-11-19 | Biocapital Holdings, Llc | Glucose sensors and methods of use thereof |
| CN111234022B (zh) * | 2019-12-16 | 2024-03-22 | 江苏省药物研究所有限公司 | 抗n-乙酰氨基葡萄糖转移酶修饰的蛋白质单克隆抗体及杂交瘤细胞株和其制备方法与应用 |
| CN112707955B (zh) * | 2020-12-21 | 2022-01-18 | 山东润德生物科技有限公司 | 提高N-乙酰氨基葡萄糖产量的RamAM转录因子突变体 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108367A0 (en) * | 1993-01-27 | 1994-04-12 | Hektoen Inst For Medical Resea | Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells |
| AU6942598A (en) * | 1997-03-31 | 1998-10-22 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | O-linked glcnac transferase (ogt): cloning, molecular expression, and methods ofuse |
| EP1102786A4 (en) * | 1998-08-03 | 2002-03-06 | Univ East Carolina | AGENT COMPRISING ANTISENSE OLIGONUCLEOTIDES WITH LOW ADENOSINE CONTENT, COMPOSITION, KIT AND TREATMENTS |
| DK2314321T3 (da) * | 1999-01-27 | 2014-09-08 | Coda Therapeutics Inc | Formuleringer, der omfatter antisense-nukleotider til connexiner |
| JP4822455B2 (ja) * | 2005-12-22 | 2011-11-24 | 株式会社Ｊ−オイルミルズ | ＧｎＴ−Ｖにより転移されたＧｌｃＮＡｃを持つ糖鎖の検出方法 |
| WO2010042228A2 (en) * | 2008-10-10 | 2010-04-15 | Cornell University | Methods for predicting disease outcome in patients with colon cancer |
| US20120046186A1 (en) * | 2010-08-20 | 2012-02-23 | Pelham Robert J | Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs |
| JP2012083193A (ja) * | 2010-10-12 | 2012-04-26 | Univ Of Tokyo | ヒストンタンパク質のグリコシル化を検出するための方法、並びに当該方法に用いられる抗体 |
-
2014
- 2014-03-11 WO PCT/US2014/023525 patent/WO2014164805A1/en not_active Ceased
- 2014-03-11 US US14/774,800 patent/US20170166897A1/en not_active Abandoned
- 2014-03-11 AU AU2014248966A patent/AU2014248966A1/en not_active Abandoned
- 2014-03-11 KR KR1020157028279A patent/KR20150126048A/ko not_active Withdrawn
- 2014-03-11 SG SG11201507211YA patent/SG11201507211YA/en unknown
- 2014-03-11 MX MX2015012124A patent/MX2015012124A/es unknown
- 2014-03-11 CN CN201480026966.0A patent/CN105408480A/zh active Pending
- 2014-03-11 RU RU2015138544A patent/RU2015138544A/ru not_active Application Discontinuation
- 2014-03-11 EP EP14779180.0A patent/EP2970978A4/en not_active Withdrawn
- 2014-03-11 CA CA2905337A patent/CA2905337A1/en not_active Abandoned
- 2014-03-11 JP JP2016501273A patent/JP2016513968A/ja not_active Withdrawn
- 2014-03-11 BR BR112015022701A patent/BR112015022701A2/pt not_active IP Right Cessation
-
2015
- 2015-09-11 CL CL2015002599A patent/CL2015002599A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2970978A4 (en) | 2016-11-02 |
| RU2015138544A (ru) | 2017-04-18 |
| CL2015002599A1 (es) | 2016-08-26 |
| US20170166897A1 (en) | 2017-06-15 |
| KR20150126048A (ko) | 2015-11-10 |
| JP2016513968A (ja) | 2016-05-19 |
| AU2014248966A1 (en) | 2015-10-29 |
| SG11201507211YA (en) | 2015-10-29 |
| BR112015022701A2 (pt) | 2018-09-25 |
| CA2905337A1 (en) | 2014-10-09 |
| EP2970978A1 (en) | 2016-01-20 |
| WO2014164805A1 (en) | 2014-10-09 |
| CN105408480A (zh) | 2016-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3055318A4 (en) | Dihydroxyalkyl substituted polygalactomannan, and methods for producing and using the same | |
| EP2991723A4 (en) | Molded headers for implantable signal generators, and associated systems and methods | |
| MX2015008999A (es) | Inhibidores mk2 y usos de los mismos. | |
| EP3008168A4 (en) | Sc- cells and compositions and methods for generating the same | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| EP2999471A4 (en) | Systems, methods, and compositions for cross-linking | |
| EP3030212A4 (en) | Long-term packaging for the protection of implant electronics | |
| EP3052638A4 (en) | Glucosyl stevia composition | |
| EP2965347A4 (en) | Ion implantation compositions, systems, and methods | |
| DK3027701T3 (en) | Compositions comprising 1,1-difluoroethene (r-1132a) | |
| ZA201509016B (en) | Compositions, methods & systems for respiratory delivery of three or more active agents | |
| PT2829250T (pt) | Implante dentário, pilar, sistema de implante e conjunto de implantação | |
| EP3003358A4 (en) | Compositions, methods, and devices for dialysis | |
| CY1120759T1 (el) | Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης | |
| GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
| EA033491B1 (ru) | Конъюгатные вакцины на основе сальмонеллы | |
| PH12013501311A1 (en) | Polymer systems | |
| EP3090025A4 (en) | Dye, filler made therefrom, compositions including the filler, and method of determining degree of cure of such compositions | |
| EP3313384A4 (en) | THERAPEUTIC IMMUNE MODULATION USING NOBLE GAS COMPOSITIONS | |
| EP3049444A4 (en) | Systems, methods, and compositions for viral-associated tumors | |
| WO2014194053A3 (en) | Carbohydrate compounds for nutritional and therapeutic use | |
| IL252683A0 (en) | Pyridyl-cycloalkyl-substituted carboxylic acids, preparations containing them and their medical uses | |
| MX2015013021A (es) | 5-bromo-indirrubinas. | |
| MX2015016603A (es) | Composiciones de corticosteroides. | |
| MX2016003207A (es) | Composiciones que comprenden colina y derivados de esta, usos de las composiciones y procesos para su preparacion. |